Peptide Library

Not FDA-approved

Brain & sleep

PT-141

Evidence

Limited human data

Class

Melanocortin receptor agonist

KEY TAKEAWAY

PT-141 is the research name for bremelanotide, a synthetic peptide that activates melanocortin receptors in the brain. The approved version is sold as Vyleesi. Bremelanotide (Vyleesi) is FDA-approved for hypoactive sexual desire disorder in premenopausal women. Products sold as PT-141 outside that approved drug are not FDA-approved.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Melanocortin receptor agonist

Main uses

Low sexual desire in premenopausal women (as approved bremelanotide)

Key fact

Bremelanotide (Vyleesi) is FDA-approved for hypoactive sexual desire disorder in premenopausal women. Products sold as PT-141 outside that approved drug are not FDA-approved.

Route

Subcutaneous injection before sexual activity (approved product)

Evidence strength

Limited human data

What it is

What it is

PT-141 is the research name for bremelanotide, a synthetic peptide that activates melanocortin receptors in the brain. The approved version is sold as Vyleesi.

How it works

How it works

It acts on melanocortin receptors in the central nervous system that are involved in sexual desire, rather than on blood flow.

Regulatory status

Regulatory status

Bremelanotide (Vyleesi) is FDA-approved for hypoactive sexual desire disorder in premenopausal women. Products sold as PT-141 outside that approved drug are not FDA-approved.

What it is used for

What it is used for

Low sexual desire in premenopausal women (as approved bremelanotide).

Side effects and risks

Side effects and risks

Nausea, flushing and headache are common, and blood pressure can rise temporarily. Repeated use can darken the skin.

Citations

Citations

PT-141: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo